The Archer FusionPlex Lymphoma Kit is a targeted next generation sequencing assay to simultaneously detect and identify fusions, point mutations, and expression levels found in RNA transcripts in 125 genes that are linked to lymphomas. Using Anchored
Multiplex PCR-based enrichment (AMPTM), fusions can be identified even without prior knowledge of fusion partners or breakpoints. Additionally, select genes are targeted for molecular barcode-enabled relative expression detection
and coverage over key hotspot regions.